|
1
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang M and Du X: Noncoding RNAs in
gastric cancer: Research progress and prospects. World J
Gastroenterol. 22:6610–6618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang R, Xia LQ, Lu WW, Zhang J and Zhu
JS: LncRNAs and cancer. Oncol Lett. 12:1233–1239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan YH, Fang H, Ji CX, Xie H, Xiao B and
Zhu XG: Long noncoding RNA CCAT2 can predict metastasis and poor
prognosis: A meta-analysis. Clin Chim Acta. 466:120–126. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ
and Hu JH: Long non-coding RNA CCAT2 is up-regulated in gastric
cancer and associated with poor prognosis. Int J Clin Exp Pathol.
8:779–785. 2015.PubMed/NCBI
|
|
7
|
Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and
Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer
proliferation and invasion by regulating the E-cadherin and LATS2.
Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao X, Ma C, Cai X, Lei D, Liu D, Xu F,
Jin T, Liu J and Pan X: RNA interference of caveolin-1 via
lentiviral vector inhibits growth of hypopharyngeal squamous cell
carcinoma FaDu cells in vitro and in vivo. Asian Pac J Cancer Prev.
12:397–401. 2011.PubMed/NCBI
|
|
10
|
Sun W, Yang Y, Xu C, Xie Y and Guo J:
Roles of long noncoding RNAs in gastric cancer and their clinical
applications. J Cancer Res ClinOncol. 142:2231–2237. 2016.
View Article : Google Scholar
|
|
11
|
Chen S, Wu H, Lv N, Wang H, Wang Y, Tang
Q, Shao H and Sun C: LncRNA CCAT2 predicts poor prognosis and
regulates growth and metastasis in small cell lung cancer. Biomed
Pharmacother. 82:583–588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ouyang S, Zhang P, Wang J, Huang Z and
Liao L: Expression of long non-coding RNA colon cancer associated
transcript 2 and its clinicopathologic significance in oral
squamous cell carcinoma. Zhonghua Kou Qiang Yi XueZaZhi.
51:286–291. 2016.(In Chinese).
|
|
13
|
Huang S, Qing C, Huang Z and Zhu Y: The
long non-coding RNA CCAT2 is up-regulated in ovarian cancer and
associated with poor prognosis. Diagn Pathol. 11:492016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou N, Si Z, Li T, Chen G, Zhang Z and Qi
H: Long non-coding RNA CCAT2 functions as an oncogene in
hepatocellular carcinoma, regulating cellular proliferation,
migration and apoptosis. Oncol Lett. 12:132–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Redis RS, Vela LE, Lu W, Ferreira de
Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B,
Taguchi A, Chen Y, et al: Allele-specific reprogramming of cancer
metabolism by the long non-coding RNA CCAT2. Mol Cell. 61:520–534.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Redis RS and Calin GA: The interplay
between lnRNAs, SNPs, and protein complexes-what does it mean for
cancer metabolism? Mol Cell Oncol. 3:e11663082016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barry KH, Moore LE, Sampson J, Yan L,
Meyer A, Oler AJ, Chung CC, Wang Z, Yeager M, Amundadottir L and
Berndt SI: DNA methylation levels at chromosome 8q24 in peripheral
blood are associated with 8q24 cancer susceptibility loci. Cancer
Prev Res (Phila). 7:1282–1292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brisbin AG, Asmann YW, Song H, Tsai YY,
Aakre JA, Yang P, Jenkins RB, Pharoah P, Schumacher F, Conti DV, et
al: Meta-analysis of 8q24 for seven cancers reveals a locus between
NOV and ENPP2 associated with cancer development. BMC Med Genet.
12:1562011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Breyer JP, Dorset DC, Clark TA, Bradley
KM, Wahlfors TA, McReynolds KM, Maynard WH, Chang SS, Cookson MS,
Smith JA, et al: An expressed retrogene of the master embryonic
stem cell gene POU5F1 is associated with prostate cancer
susceptibility. Am J Hum Genet. 94:395–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hayashi H, Arao T, Togashi Y, Kato H,
Fujita Y, De Velasco MA, Kimura H, Matsumoto K, Tanaka K, Okamoto
I, et al: The OCT4 pseudogene POU5F1B is amplified and promotes an
aggressive phenotype in gastric cancer. Oncogene. 34:199–208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu G, Pei F, Yang F, Li L, Amin AD, Liu
S, Buchan JR and Cho WC: Role of autophagy and apoptosis in
non-small-cell lung cancer. Int J Mol Sci. 18:E3672017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou H, Yuan M, Yu Q, Zhou X, Min W and
Gao D: Autophagy regulation and its role in gastric cancer and
colorectal cancer. Cancer Biomark. 17:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu LL, Cheng Y and Liu B: Beclin-1:
Autophagic regulator and therapeutic target in cancer. Int J
Biochem Cell Biol. 45:921–924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu ZY, Ding J, Yang XF and Zhang ZM:
Significance of autophagy-related protein beclin-1 expression in
gastric cancer: A Meta-analysis. Chin J Gen Surg. 24:1389–1395.
2015.
|
|
25
|
He Y, Zhao X, Subahan NR, Fan L, Gao J and
Chen H: The prognostic value of autophagy-related markers beclin-1
and microtubule-associated protein light chain 3B in cancers: A
systematic review and meta-analysis. Tumour Biol. 35:7317–7326.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao QH, Liu F, Yang ZL, Fu XH, Yang ZH,
Liu Q, Wang L, Wan XB and Fan XJ: Prognostic value of autophagy
related proteins ULK1, Beclin 1, ATG3, ATG5, ATG7, ATG9, ATG10,
ATG12, LC3B and p62/SQSTM1 in gastric cancer. Am J Transl Res.
8:3831–3847. 2016.PubMed/NCBI
|
|
27
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu M, Li CM, Chen ZF, Ji R, Guo QH, Li Q,
Zhang HL and Zhou YN: Celecoxib regulates apoptosis and autophagy
via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer
cells. Int J Mol Med. 33:1451–1458. 2014. View Article : Google Scholar : PubMed/NCBI
|
